Annual Retained Earnings
-$924.39 M
-$402.27 M-77.04%
December 31, 2023
Summary
- As of February 20, 2025, PCVX annual retained earnings is -$924.39 million, with the most recent change of -$402.27 million (-77.04%) on December 31, 2023.
- During the last 3 years, PCVX annual retained earnings has fallen by -$725.83 million (-365.54%).
- PCVX annual retained earnings is now -1464.83% below its all-time high of -$59.07 million, reached on December 31, 2018.
Performance
PCVX Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Retained Earnings
-$1.25 B
-$103.12 M-8.98%
September 30, 2024
Summary
- As of February 20, 2025, PCVX quarterly retained earnings is -$1.25 billion, with the most recent change of -$103.12 million (-8.98%) on September 30, 2024.
- Over the past year, PCVX quarterly retained earnings has stayed the same.
- PCVX quarterly retained earnings is now -1044.28% below its all-time high of -$109.35 million, reached on December 31, 2019.
Performance
PCVX Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Retained Earnings Formula
Retained Earnings = Retained Earnings (start of the period) + Net Income − Dividends Paid
PCVX Retained Earnings Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -77.0% | 0.0% |
3 y3 years | -365.5% | -363.3% |
5 y5 years | -1464.8% | - |
PCVX Retained Earnings Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -209.5% | at low | -319.0% | at low |
5 y | 5-year | -745.4% | at low | -1044.3% | at low |
alltime | all time | -1464.8% | at low | -1044.3% | at low |
Vaxcyte Retained Earnings History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | -$1.25 B(+9.0%) |
Jun 2024 | - | -$1.15 B(+12.6%) |
Mar 2024 | - | -$1.02 B(+10.3%) |
Dec 2023 | -$924.39 M(+77.0%) | -$924.39 M(+24.3%) |
Sep 2023 | - | -$743.59 M(+14.2%) |
Jun 2023 | - | -$650.93 M(+11.7%) |
Mar 2023 | - | -$582.59 M(+11.6%) |
Dec 2022 | -$522.13 M | -$522.13 M(+17.6%) |
Sep 2022 | - | -$444.08 M(+15.0%) |
Jun 2022 | - | -$386.16 M(+14.4%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | -$337.63 M(+13.1%) |
Dec 2021 | -$298.64 M(+50.4%) | -$298.64 M(+10.6%) |
Sep 2021 | - | -$270.08 M(+10.9%) |
Jun 2021 | - | -$243.46 M(+10.8%) |
Mar 2021 | - | -$219.78 M(+10.7%) |
Dec 2020 | -$198.56 M(+81.6%) | -$198.56 M(+11.7%) |
Sep 2020 | - | -$177.83 M(+13.4%) |
Jun 2020 | - | -$156.81 M(+14.9%) |
Mar 2020 | - | -$136.49 M(+24.8%) |
Dec 2019 | -$109.35 M(+85.1%) | -$109.35 M |
Dec 2018 | -$59.07 M | - |
FAQ
- What is Vaxcyte annual retained earnings?
- What is the all time high annual retained earnings for Vaxcyte?
- What is Vaxcyte annual retained earnings year-on-year change?
- What is Vaxcyte quarterly retained earnings?
- What is the all time high quarterly retained earnings for Vaxcyte?
- What is Vaxcyte quarterly retained earnings year-on-year change?
What is Vaxcyte annual retained earnings?
The current annual retained earnings of PCVX is -$924.39 M
What is the all time high annual retained earnings for Vaxcyte?
Vaxcyte all-time high annual retained earnings is -$59.07 M
What is Vaxcyte annual retained earnings year-on-year change?
Over the past year, PCVX annual retained earnings has changed by -$402.27 M (-77.04%)
What is Vaxcyte quarterly retained earnings?
The current quarterly retained earnings of PCVX is -$1.25 B
What is the all time high quarterly retained earnings for Vaxcyte?
Vaxcyte all-time high quarterly retained earnings is -$109.35 M
What is Vaxcyte quarterly retained earnings year-on-year change?
Over the past year, PCVX quarterly retained earnings has changed by $0.00 (0.00%)